US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
WO2000018374A1
(en)
*
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US7815937B2
(en)
*
|
1998-10-27 |
2010-10-19 |
Biovail Laboratories International Srl |
Quick dissolve compositions and tablets based thereon
|
AU1323400A
(en)
*
|
1998-10-27 |
2000-05-15 |
Fuisz Technologies Ltd. |
Microparticles containing peg and/or peg glyceryl esters
|
DK1126826T6
(en)
|
1998-11-02 |
2019-06-24 |
Alkermes Pharma Ireland Ltd |
Multiparticulate modified release of methylphenidate
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
DE19931708A1
(en)
*
|
1999-07-08 |
2001-01-18 |
Bayer Ag |
Process for the preparation of rapidly disintegrating solid pharmaceutical preparations
|
UY26615A1
(en)
*
|
2000-03-16 |
2001-10-25 |
Pfizer Prod Inc |
GLUCOGEN PHOSPHORYLASE INHIBITOR.
|
US7575761B2
(en)
*
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
US6656492B2
(en)
*
|
2000-06-30 |
2003-12-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Quick disintegrating tablet in buccal cavity and manufacturing method thereof
|
US20100010101A1
(en)
*
|
2000-07-05 |
2010-01-14 |
Capricorn Pharma, Inc. |
Rapid-Melt Compositions and Methods of Making Same
|
AU2001277230A1
(en)
*
|
2000-08-01 |
2002-02-13 |
Inhale Therapeutic Systems, Inc. |
Apparatus and process to produce particles having a narrow size distribution andparticles made thereby
|
CN1638739A
(en)
*
|
2000-08-18 |
2005-07-13 |
法玛西雅厄普约翰美国公司 |
Compound for treating assuetude disturbance
|
US20040043061A1
(en)
*
|
2000-09-15 |
2004-03-04 |
Leon Daniel S. |
Dissolvable films comprising suspended, non-soluble pharmaceutically active ingredients, apparatus and methods for their manufacture and use
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
US6982251B2
(en)
*
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US6559180B2
(en)
|
2001-03-27 |
2003-05-06 |
Yuri Busiashvili |
Nitroglycerin-menthol potentiation for treatment of angina
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
JP2005504266A
(en)
*
|
2001-06-22 |
2005-02-10 |
エラン ファーマ インターナショナル,リミティド |
High-throughput screening methods using small-scale mills or microfluidics
|
ATE243028T1
(en)
*
|
2001-07-11 |
2003-07-15 |
Applied Pharma Res |
GRANULES CONTAINING FAT-SOLUBLE SUBSTANCES AND METHOD FOR THE PRODUCTION THEREOF
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
DE60217367T2
(en)
*
|
2001-09-19 |
2007-10-18 |
Elan Pharma International Ltd. |
NANOPARTICLE COMPOSITIONS CONTAINING INSULIN
|
KR20040058189A
(en)
*
|
2001-09-26 |
2004-07-03 |
파마시아 코포레이션 |
Organoleptically acceptable intraorally disintegrating compositions
|
CA2461349C
(en)
|
2001-09-26 |
2011-11-29 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
OA12666A
(en)
*
|
2001-10-10 |
2006-06-19 |
Pharmacia Corp Corporate Paten |
Intraorally disintegrating valdecoxib compositionsprepared by spray drying process.
|
JP2005508939A
(en)
*
|
2001-10-12 |
2005-04-07 |
エラン ファーマ インターナショナル,リミティド |
Composition having combined immediate release and sustained release characteristics
|
MY148466A
(en)
*
|
2001-10-26 |
2013-04-30 |
Merck Frosst Canada Ltd |
Granule formulation
|
CA2363528A1
(en)
*
|
2001-11-19 |
2003-05-19 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Immediate release tablet containing naproxen sodium
|
US20030129250A1
(en)
*
|
2001-11-20 |
2003-07-10 |
Advanced Inhalation Research Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
FR2834889B1
(en)
*
|
2002-01-18 |
2004-04-02 |
Roquette Freres |
SOLID ORODISPERSIBLE PHARMACEUTICAL FORM
|
JP2005517690A
(en)
*
|
2002-02-01 |
2005-06-16 |
ファイザー・プロダクツ・インク |
Immediate release dosage form containing solid drug dispersion
|
CA2475092C
(en)
|
2002-02-04 |
2012-05-01 |
Christian F. Wertz |
Nanoparticulate compositions having lysozyme as a surface stabilizer
|
AU2003209475A1
(en)
*
|
2002-03-07 |
2003-09-16 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
US20050191357A1
(en)
*
|
2002-03-20 |
2005-09-01 |
Yoshiaki Kawashima |
Method of manufacturing chemical-containing composite particles
|
US20030215502A1
(en)
*
|
2002-03-20 |
2003-11-20 |
Elan Pharma International Limited |
Fast dissolving dosage forms having reduced friability
|
CA2479665C
(en)
*
|
2002-03-20 |
2011-08-30 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US9101540B2
(en)
*
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
ES2380318T3
(en)
|
2002-04-12 |
2012-05-10 |
Alkermes Pharma Ireland Limited |
Megestrol nanoparticular formulations
|
US7101576B2
(en)
*
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US6592852B1
(en)
*
|
2002-04-25 |
2003-07-15 |
Unilever Home & Personal Care Usa, Division Of Conopco, Inc. |
Zinc citrate beads in oral compositions
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
AU2003234452A1
(en)
*
|
2002-05-06 |
2003-11-11 |
Elan Pharma International Ltd. |
Nanoparticulate nystatin formulations
|
US20030215498A1
(en)
*
|
2002-05-17 |
2003-11-20 |
Harland Ronald S. |
Rapidly disintegrating comressed tablets comprising biologically active compounds
|
AU2003241477A1
(en)
*
|
2002-06-10 |
2003-12-22 |
Elan Pharma International, Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
US20030228370A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Michel Serpelloni |
Orodispersible solid pharmaceutical form
|
US20040258757A1
(en)
*
|
2002-07-16 |
2004-12-23 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
US7445796B2
(en)
*
|
2002-08-19 |
2008-11-04 |
L. Perrigo Company |
Pharmaceutically active particles of a monomodal particle size distribution and method
|
ATE487470T1
(en)
*
|
2002-09-11 |
2010-11-15 |
Elan Pharma Int Ltd |
GEL-STABILIZED ACTIVE COMPOSITIONS IN NANOPARTICLE SIZE
|
WO2004032980A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
US20060134195A1
(en)
*
|
2002-11-25 |
2006-06-22 |
Yourong Fu |
Mannose-based fast dissolving tablets
|
US20040173696A1
(en)
*
|
2002-12-17 |
2004-09-09 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
MXPA05007154A
(en)
|
2002-12-30 |
2005-09-21 |
Nektar Therapeutics |
Prefilming atomizer.
|
US8367111B2
(en)
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
CA2513064C
(en)
*
|
2003-01-31 |
2009-11-10 |
Elan Pharma International, Ltd. |
Nanoparticulate topiramate formulations
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
US8512727B2
(en)
*
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
JP5137228B2
(en)
|
2003-03-07 |
2013-02-06 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Substituted azetidinone compounds, substituted azetidinone formulations and their use for the treatment of hypercholesterolemia
|
DE602004018617D1
(en)
|
2003-03-07 |
2009-02-05 |
Schering Corp |
SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE FOR THE TREATMENT OF HYPERCHOLESTEROLMIA
|
EP1620075B1
(en)
*
|
2003-05-07 |
2020-06-24 |
Samyang Biopharmaceuticals Corporation |
Highly plastic granules for making fast melting tablets
|
US7354601B2
(en)
|
2003-05-08 |
2008-04-08 |
Walker Stephen E |
Particulate materials
|
JP2007501683A
(en)
*
|
2003-05-22 |
2007-02-01 |
エラン ファーマ インターナショナル リミテッド |
Sterilization of nanoparticle active substance dispersions by gamma irradiation
|
US20060226234A1
(en)
*
|
2003-06-11 |
2006-10-12 |
Kettinger Frederick R |
Pharmaceutical dosage forms having overt and covert markings for identification and authentification
|
FR2858556B1
(en)
*
|
2003-08-06 |
2006-03-10 |
Galenix Innovations |
DISPERSIBLE AND / OR ORODISPERSIBLE SOLID PHARMACEUTICAL COMPOSITION, NOT PELLETIZED, CONTAINING AT LEAST THE METFORMIN ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE SAME
|
ES2318330T3
(en)
*
|
2003-08-08 |
2009-05-01 |
Elan Pharma International Limited |
NEW COMPOSITIONS OF METAXALONA.
|
US20050036977A1
(en)
*
|
2003-08-11 |
2005-02-17 |
Dilip Gole |
Taste-masked resinate and preparation thereof
|
US7390503B1
(en)
|
2003-08-22 |
2008-06-24 |
Barr Laboratories, Inc. |
Ondansetron orally disintegrating tablets
|
US20050053655A1
(en)
*
|
2003-09-05 |
2005-03-10 |
Pharmaceutical Industry Technology And Development Center |
Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same
|
CA2540040C
(en)
*
|
2003-10-07 |
2012-09-11 |
Andrx Pharmaceuticals Llc |
Rapidly disintegrating formulation
|
JP3841804B2
(en)
|
2003-10-15 |
2006-11-08 |
富士化学工業株式会社 |
Composition for intraorally rapidly disintegrating tablets
|
US8349361B2
(en)
|
2003-10-15 |
2013-01-08 |
Fuji Chemical Industry Co., Ltd. |
Composition for rapid disintegrating tablet in oral cavity
|
US20050196441A1
(en)
*
|
2003-11-05 |
2005-09-08 |
Dvorsky James E. |
Quick dissolving agrochemical and animal health products
|
ES2366646T3
(en)
*
|
2003-11-05 |
2011-10-24 |
Elan Pharma International Limited |
COMPOSITIONS IN THE FORM OF NANOPARTICLES THAT HAVE A PEPTIDE AS A SURFACE STABILIZER.
|
JP2007517015A
(en)
*
|
2003-12-31 |
2007-06-28 |
ファイザー・プロダクツ・インク |
Stabilized pharmaceutical solid composition of low solubility drug, poloxamer and stabilizing polymer
|
WO2005065657A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Pfizer Products Inc. |
Solid compositions of low-solubility drugs and poloxamers
|
US7785619B2
(en)
*
|
2004-04-08 |
2010-08-31 |
Micro Nutrient, Llc |
Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
|
US7850987B2
(en)
*
|
2004-04-08 |
2010-12-14 |
Micronutrient, Llc |
Nutrient composition(s) and system(s) for individualized, responsive dosing regimens
|
WO2005097085A1
(en)
*
|
2004-04-08 |
2005-10-20 |
Micro Nutrient, Llc |
Nutrient system for individualized responsive dosing regimens
|
US20060013873A1
(en)
*
|
2004-07-16 |
2006-01-19 |
Chih-Chiang Yang |
Bioadhesive dosage form of steroids
|
US7956222B2
(en)
*
|
2004-08-17 |
2011-06-07 |
Eisai R&D Management Co., Ltd |
Methods for producing dibromofluorobenzene derivatives
|
US20140162965A1
(en)
|
2004-08-25 |
2014-06-12 |
Aegis Therapeutics, Inc. |
Compositions for oral drug administration
|
US20060046962A1
(en)
|
2004-08-25 |
2006-03-02 |
Aegis Therapeutics Llc |
Absorption enhancers for drug administration
|
US20090047347A1
(en)
*
|
2005-07-29 |
2009-02-19 |
Aegis Therapeutics, Inc. |
Compositions for Drug Administration
|
US9895444B2
(en)
|
2004-08-25 |
2018-02-20 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
US9114069B2
(en)
*
|
2004-08-25 |
2015-08-25 |
Aegis Therapeutics, Llc |
Antibacterial compositions for drug administration
|
US8747895B2
(en)
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
NZ589750A
(en)
|
2004-10-21 |
2012-07-27 |
Aptalis Pharmatech Inc |
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
EA200701065A1
(en)
*
|
2004-11-16 |
2007-12-28 |
Элан Фарма Интернэшнл Лтд. |
INJECTABLE COMPOSITIONS CONTAINING NANODISPERS Olanzapine
|
UA89513C2
(en)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Nanoparticulate raloxifene hydrochloride composition
|
WO2006062875A1
(en)
*
|
2004-12-08 |
2006-06-15 |
Merck & Co., Inc. |
Ophthalmic nanoparticulate formulation of a cyclooxygenase-2 selective inhibitor
|
JP2008524239A
(en)
*
|
2004-12-15 |
2008-07-10 |
エラン ファーマ インターナショナル リミティド |
Nanoparticulate tacrolimus formulation
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
AU2012201630B8
(en)
*
|
2004-12-31 |
2014-03-06 |
Iceutica Pty Ltd |
NanoParticle Composition(s) and Method for Synthesis Thereof
|
EP1835890A2
(en)
*
|
2005-01-06 |
2007-09-26 |
Elan Pharma International Limited |
Nanoparticulate candesartan formulations
|
AU2006214443C1
(en)
|
2005-02-15 |
2011-11-24 |
Alkermes Pharma Ireland Limited |
Aerosol and injectable formulations of nanoparticulate benzodiazepine
|
WO2006099121A2
(en)
*
|
2005-03-10 |
2006-09-21 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof
|
CA2601179A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Elan Pharma International Limited |
Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
|
JP2008533173A
(en)
*
|
2005-03-17 |
2008-08-21 |
エラン ファーマ インターナショナル リミテッド |
Nanoparticulate bisphosphonate composition
|
KR20070121786A
(en)
*
|
2005-03-23 |
2007-12-27 |
엘란 파마 인터내셔널 리미티드 |
Nanoparticulate corticosteroid and antihistamine formulations
|
ES2390804T3
(en)
|
2005-04-08 |
2012-11-16 |
Ptc Therapeutics, Inc. |
Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
|
BRPI0607537A2
(en)
*
|
2005-04-12 |
2009-09-15 |
Elan Pharma Int Ltd |
nanoparticulate quinazoline derivative formulations
|
CN101171000A
(en)
*
|
2005-04-12 |
2008-04-30 |
依兰药物国际有限公司 |
Nanoparticulate and controlled release compositions comprising cyclosporine
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
JP2009517485A
(en)
|
2005-06-08 |
2009-04-30 |
エラン・ファルマ・インターナショナル・リミテッド |
Nanoparticulate and controlled release compositions containing cefditoren
|
CA2617557A1
(en)
|
2005-08-04 |
2007-02-15 |
Sirtris Pharmaceuticals, Inc. |
Benzimidazole derivatives as sirtuin modulators
|
JP2009508859A
(en)
|
2005-09-15 |
2009-03-05 |
エラン ファーマ インターナショナル リミテッド |
Nanoparticulate aripiprazole formulation
|
KR20080070848A
(en)
*
|
2005-11-03 |
2008-07-31 |
레드포인트 바이오 코포레이션 |
Hydrazone derivatives and uses thereof
|
US7811604B1
(en)
|
2005-11-14 |
2010-10-12 |
Barr Laboratories, Inc. |
Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
|
EA017290B1
(en)
*
|
2005-11-28 |
2012-11-30 |
Домейн Раша Инвестментс Лимитед |
Ganaxolone-based formulations
|
JP3884056B1
(en)
*
|
2006-01-27 |
2007-02-21 |
秋山錠剤株式会社 |
Method for producing intraoral rapidly disintegrating tablet
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
US20070243248A1
(en)
*
|
2006-04-14 |
2007-10-18 |
Cherukuri S Rao |
Rapidly disintegrating solid oral dosage form of liquid dispersions
|
US8226949B2
(en)
|
2006-06-23 |
2012-07-24 |
Aegis Therapeutics Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
AU2007265452A1
(en)
*
|
2006-06-26 |
2008-01-03 |
Mutual Pharmaceutical Company, Inc. |
Active agent formulations, methods of making, and methods of use
|
JP5508003B2
(en)
*
|
2006-06-30 |
2014-05-28 |
アイスイティカ ピーティーワイ リミテッド |
Process for the preparation of biologically active compounds in nanoparticulate form
|
EP1891938A1
(en)
*
|
2006-07-24 |
2008-02-27 |
Cephalon France |
High dose orally dissolvable/disintegrable lyophilized dosage form
|
US20080031947A1
(en)
*
|
2006-07-24 |
2008-02-07 |
Cima Labs Inc. |
Orally dissolvable/disintegrable lyophilized dosage forms containing protected
|
BRPI0716053A2
(en)
*
|
2006-08-22 |
2013-08-06 |
Redpoint Bio Corp |
heterocyclic compounds as sweetener promoters
|
US8124598B2
(en)
|
2006-09-14 |
2012-02-28 |
Sharon Sageman |
7-keto DHEA for psychiatric use
|
WO2008033545A2
(en)
*
|
2006-09-15 |
2008-03-20 |
Redpoint Bio Corporation |
Triphenylphosphine oxide derivatives and uses thereof
|
US20080153845A1
(en)
*
|
2006-10-27 |
2008-06-26 |
Redpoint Bio Corporation |
Trpv1 antagonists and uses thereof
|
JP2010510988A
(en)
*
|
2006-11-28 |
2010-04-08 |
マリナス ファーマシューティカルズ |
Nanoparticle formulation, method for producing the same and use thereof
|
ES2531929T3
(en)
*
|
2006-12-20 |
2015-03-20 |
Teva Women's Health, Inc. |
Solid dosage forms that disintegrate in the mouth that comprise progestin and methods for making and using them
|
EP1935405A1
(en)
*
|
2006-12-22 |
2008-06-25 |
LEK Pharmaceuticals D.D. |
Orally disintegrating tablets
|
BRPI0808157A2
(en)
*
|
2007-02-02 |
2014-07-01 |
Redpoint Bio Corp |
USE OF TRPM5 INHIBITOR FOR REGULATING INSULIN AND GLP-1 RELEASE
|
JP3967767B1
(en)
*
|
2007-02-08 |
2007-08-29 |
秋山錠剤株式会社 |
Method for producing intraoral rapidly disintegrating tablet
|
KR20090129998A
(en)
|
2007-02-11 |
2009-12-17 |
맵 파마슈티컬스, 인코포레이티드 |
Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
|
US20090004231A1
(en)
|
2007-06-30 |
2009-01-01 |
Popp Shane M |
Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
|
US8968709B2
(en)
|
2007-07-25 |
2015-03-03 |
3M Innovative Properties Company |
Therapeutic dental composition and related methods
|
US20100160274A1
(en)
*
|
2007-09-07 |
2010-06-24 |
Sharon Sageman |
7-KETO DHEA for Psychiatric Use
|
WO2009082478A1
(en)
|
2007-12-20 |
2009-07-02 |
Duramed Pharmaceuticals, Inc. |
Dosage regimens and pharmaceutical compositions and packages for emergency contraception
|
CA2756690C
(en)
|
2008-03-28 |
2016-08-16 |
Hale Biopharma Ventures, Llc |
Administration of benzodiazepine compositions
|
WO2009124357A1
(en)
*
|
2008-04-10 |
2009-10-15 |
Malvin Leonard Eutick |
Fast dissolving oral formulations for critical drugs
|
EP2293779A1
(en)
*
|
2008-04-24 |
2011-03-16 |
Evestra, Inc. |
Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
|
TR201808694T4
(en)
*
|
2008-06-20 |
2018-07-23 |
Merck Patent Gmbh |
Direct compressible and fast disintegrating tablet matrix.
|
DE102008047910A1
(en)
|
2008-09-19 |
2010-03-25 |
Molkerei Meggle Wasserburg Gmbh & Co. Kg |
Tabletting excipient based on lactose and cellulose
|
CA2750216A1
(en)
*
|
2008-12-15 |
2010-07-08 |
Fleming And Company, Pharmaceuticals |
Rapidly dissolving vitamin formulation and methods of using the same
|
US8440631B2
(en)
|
2008-12-22 |
2013-05-14 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
US20100159010A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
AU2010239081C1
(en)
|
2009-04-24 |
2014-11-06 |
Iceutica Pty Ltd |
A novel formulation of indomethacin
|
EP2253306A1
(en)
|
2009-05-18 |
2010-11-24 |
Royal College of Surgeons in Ireland |
Orodispersible dosage forms containing solid drug dispersions
|
FR2945950A1
(en)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
ANTICANCER NANOPARTICLE COMPOSITIONS AND METHODS FOR PREPARING THE SAME
|
AU2010254180B2
(en)
|
2009-05-27 |
2015-08-27 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
SG178376A1
(en)
|
2009-09-04 |
2012-03-29 |
Redpoint Bio Corp |
Sweetness enhancers including rebaudioside a or d
|
US9775819B2
(en)
*
|
2009-09-16 |
2017-10-03 |
R.P. Scherer Technologies, Llc |
Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
|
US20120230922A1
(en)
|
2009-09-22 |
2012-09-13 |
Redpoint Bio Corporation |
Novel Polymorphs of Rebaudioside C and Methods for Making and Using the Same
|
JP5309262B2
(en)
|
2009-12-02 |
2013-10-09 |
アプタリス ファーマ リミテッド |
Fexofenadine microcapsule and composition containing the same
|
WO2011146583A2
(en)
|
2010-05-19 |
2011-11-24 |
Elan Pharma International Limited |
Nanoparticulate cinacalcet formulations
|
MX2013002430A
(en)
|
2010-09-01 |
2013-07-22 |
Arena Pharm Inc |
Fast-dissolve dosage forms of 5-ht2c agonists.
|
US10238684B2
(en)
|
2010-11-18 |
2019-03-26 |
Foundational Biosystems, Llc |
Micro- and nano-quantity sleep enhancing nutrient composition and method of enhancing central nervous system protein clearance using same
|
MX350838B
(en)
|
2011-02-11 |
2017-09-18 |
Grain Proc Corporation * |
Salt composition.
|
WO2012174158A2
(en)
|
2011-06-14 |
2012-12-20 |
Hale Biopharma Ventures, Llc |
Administration of benzodiazepine
|
CN103987840A
(en)
|
2011-08-08 |
2014-08-13 |
国际香料香精公司 |
Compositions and methods for the biosynthesis of vanillin or vanillin beta-D-glucoside
|
TWI526210B
(en)
*
|
2012-02-15 |
2016-03-21 |
Taiho Pharmaceutical Co Ltd |
Oral pharmaceutical composition
|
JP5877778B2
(en)
*
|
2012-05-28 |
2016-03-08 |
株式会社ホットアルバム炭酸泉タブレット |
Tablet manufacturing method and tablet
|
AU2014226290B2
(en)
*
|
2013-03-04 |
2018-11-15 |
Vtv Therapeutics Llc |
Stable glucokinase activator compositions
|
JP6304896B2
(en)
*
|
2013-07-30 |
2018-04-04 |
ライオン株式会社 |
tablet
|
AU2014320088B2
(en)
|
2013-09-16 |
2017-06-01 |
Astrazeneca Ab |
Therapeutic polymeric nanoparticles and methods of making and using same
|
KR20160108828A
(en)
|
2013-11-11 |
2016-09-20 |
임팩스 라보라토리즈, 인코포레이티드 |
Rapidly disintegrating formulations and methods of use
|
EP2880992A3
(en)
|
2013-12-05 |
2015-06-17 |
International Flavors & Fragrances Inc. |
Rebaudioside C and its stereoisomers as natural product sweetness enhancers
|
CN105007904A
(en)
*
|
2014-02-07 |
2015-10-28 |
科学实验室药物公司 |
All natural, non-toxic sublingual drug delivery systems
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
US10722468B2
(en)
*
|
2014-08-14 |
2020-07-28 |
Brown University |
Compositions for stabilizing and delivering proteins
|
CN107249567B
(en)
|
2014-11-21 |
2021-08-03 |
拜尔哈文制药股份有限公司 |
Sublingual administration of riluzole
|
US9925138B2
(en)
|
2015-01-20 |
2018-03-27 |
Handa Pharmaceuticals, Llc |
Stable solid fingolimod dosage forms
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
US10011629B2
(en)
|
2015-05-01 |
2018-07-03 |
Cocrystal Pharma, Inc. |
Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
|
US11173098B1
(en)
|
2016-02-05 |
2021-11-16 |
Gram Tactical Llc |
Magazines for tactical medicine dispensers
|
EP3458053B1
(en)
|
2016-05-20 |
2021-12-08 |
Biohaven Pharmaceutical Holding Company Ltd. |
Use of riluzole, riluzole prodrugs or riluzole analogs with immunotherapies to treat cancers
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
JP2019524816A
(en)
|
2016-08-11 |
2019-09-05 |
オービッド・セラピューティクス・インコーポレイテッドOvid Therapeutics, Inc. |
Methods and compositions for the treatment of epileptic disorders
|
KR20240031326A
(en)
|
2016-12-31 |
2024-03-07 |
바이오엑셀 테라퓨틱스 인코포레이티드 |
Use of Sublingual Dexmedetomidine for the treatment of Agitation
|
JP2019077644A
(en)
*
|
2017-10-25 |
2019-05-23 |
富士フイルム株式会社 |
Pharmaceutical composition and method of producing pharmaceutical composition
|
US20210023061A1
(en)
|
2017-11-12 |
2021-01-28 |
Biohaven Pharmaceutical Holding Company Ltd. |
Use of riluzole prodrugs to treat ataxias
|
EP3508199A1
(en)
*
|
2018-01-05 |
2019-07-10 |
Dompé farmaceutici S.p.A. |
Immediate-release pharmaceutical compositions containing ketoprofen lysine salt
|
CA3103431A1
(en)
|
2018-06-27 |
2020-01-02 |
Bioxcel Therapeutics, Inc. |
Film formulations containing dexmedetomidine and methods of producing them
|
CN109125775B
(en)
*
|
2018-09-25 |
2021-02-09 |
广东爱车小屋电子商务科技有限公司 |
Air freshener with lasting fragrance and preparation method thereof
|
WO2020118142A1
(en)
|
2018-12-07 |
2020-06-11 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of pospartum depression
|
CA3145388A1
(en)
|
2019-07-19 |
2021-01-28 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|
WO2021026124A1
(en)
|
2019-08-05 |
2021-02-11 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in treatment of status epilepticus
|
KR20220134529A
(en)
|
2019-12-06 |
2022-10-05 |
마리누스 파마슈티컬스 인코포레이티드 |
Ganaxolone for use in the treatment of complex tuberous sclerosis
|
WO2021222739A1
(en)
|
2020-04-30 |
2021-11-04 |
Nanocopoeia, Llc |
Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib
|
KR20230012502A
(en)
|
2020-05-18 |
2023-01-26 |
오렉쏘 에이비 |
Novel pharmaceutical compositions for drug delivery
|
EP3928772A1
(en)
|
2020-06-26 |
2021-12-29 |
Algiax Pharmaceuticals GmbH |
Nanoparticulate composition
|
IT202000025885A1
(en)
*
|
2020-10-30 |
2022-04-30 |
Vacutest Kima S R L |
URINE PRESERVATIVE COMPOSITION, URINE SAMPLING DEVICE AND METHOD FOR PRODUCTION OF URINE SAMPLING DEVICE
|
US11672761B2
(en)
|
2020-11-16 |
2023-06-13 |
Orcosa Inc. |
Rapidly infusing platform and compositions for therapeutic treatment in humans
|
AR127780A1
(en)
|
2021-11-25 |
2024-02-28 |
Orexo Ab |
NEW PHARMACEUTICAL COMPOSITION THAT COMPRISES ADRENALINE
|